Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1

3(42.9%)

Phase 2

2(28.6%)

N/A

1(14.3%)

Phase 3

1(14.3%)

7Total

Phase 1(3)

Phase 2(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02349906Phase 2Completed

Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

Role: collaborator

NCT03634085Phase 1Completed

Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects.

Role: collaborator

NCT03300453Phase 1Completed

Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome

Role: collaborator

NCT02515656Phase 3Completed

Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis

Role: collaborator

NCT02295969Completed

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Role: collaborator

NCT02303717Not ApplicableUnknown

Xience Versus Synergy in Left Main PCI

Role: collaborator

NCT00864110Phase 1Completed

Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Role: collaborator

NCT00865319Phase 2Completed

Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Role: collaborator

All 8 trials loaded